US4179337A
(en)
|
1973-07-20 |
1979-12-18 |
Davis Frank F |
Non-immunogenic polypeptides
|
US4489055A
(en)
|
1978-07-19 |
1984-12-18 |
N.V. Sopar S.A. |
Process for preparing biodegradable submicroscopic particles containing a biologically active substance and their use
|
US4289872A
(en)
|
1979-04-06 |
1981-09-15 |
Allied Corporation |
Macromolecular highly branched homogeneous compound based on lysine units
|
US4469863A
(en)
|
1980-11-12 |
1984-09-04 |
Ts O Paul O P |
Nonionic nucleic acid alkyl and aryl phosphonates and processes for manufacture and use thereof
|
US5023243A
(en)
|
1981-10-23 |
1991-06-11 |
Molecular Biosystems, Inc. |
Oligonucleotide therapeutic agent and method of making same
|
US4476301A
(en)
|
1982-04-29 |
1984-10-09 |
Centre National De La Recherche Scientifique |
Oligonucleotides, a process for preparing the same and their application as mediators of the action of interferon
|
JPS5927900A
(ja)
|
1982-08-09 |
1984-02-14 |
Wakunaga Seiyaku Kk |
固定化オリゴヌクレオチド
|
FR2540122B1
(fr)
|
1983-01-27 |
1985-11-29 |
Centre Nat Rech Scient |
Nouveaux composes comportant une sequence d'oligonucleotide liee a un agent d'intercalation, leur procede de synthese et leur application
|
US4605735A
(en)
|
1983-02-14 |
1986-08-12 |
Wakunaga Seiyaku Kabushiki Kaisha |
Oligonucleotide derivatives
|
US4587044A
(en)
|
1983-09-01 |
1986-05-06 |
The Johns Hopkins University |
Linkage of proteins to nucleic acids
|
US5008050A
(en)
|
1984-06-20 |
1991-04-16 |
The Liposome Company, Inc. |
Extrusion technique for producing unilamellar vesicles
|
US5550111A
(en)
|
1984-07-11 |
1996-08-27 |
Temple University-Of The Commonwealth System Of Higher Education |
Dual action 2',5'-oligoadenylate antiviral derivatives and uses thereof
|
FR2567892B1
(fr)
|
1984-07-19 |
1989-02-17 |
Centre Nat Rech Scient |
Nouveaux oligonucleotides, leur procede de preparation et leurs applications comme mediateurs dans le developpement des effets des interferons
|
US5430136A
(en)
|
1984-10-16 |
1995-07-04 |
Chiron Corporation |
Oligonucleotides having selectably cleavable and/or abasic sites
|
US5258506A
(en)
|
1984-10-16 |
1993-11-02 |
Chiron Corporation |
Photolabile reagents for incorporation into oligonucleotide chains
|
US5367066A
(en)
|
1984-10-16 |
1994-11-22 |
Chiron Corporation |
Oligonucleotides with selectably cleavable and/or abasic sites
|
US4828979A
(en)
|
1984-11-08 |
1989-05-09 |
Life Technologies, Inc. |
Nucleotide analogs for nucleic acid labeling and detection
|
FR2575751B1
(fr)
|
1985-01-08 |
1987-04-03 |
Pasteur Institut |
Nouveaux nucleosides de derives de l'adenosine, leur preparation et leurs applications biologiques
|
US5235033A
(en)
|
1985-03-15 |
1993-08-10 |
Anti-Gene Development Group |
Alpha-morpholino ribonucleoside derivatives and polymers thereof
|
US5034506A
(en)
|
1985-03-15 |
1991-07-23 |
Anti-Gene Development Group |
Uncharged morpholino-based polymers having achiral intersubunit linkages
|
US5185444A
(en)
|
1985-03-15 |
1993-02-09 |
Anti-Gene Deveopment Group |
Uncharged morpolino-based polymers having phosphorous containing chiral intersubunit linkages
|
US5317098A
(en)
|
1986-03-17 |
1994-05-31 |
Hiroaki Shizuya |
Non-radioisotope tagging of fragments
|
JPS638396A
(ja)
|
1986-06-30 |
1988-01-14 |
Wakunaga Pharmaceut Co Ltd |
ポリ標識化オリゴヌクレオチド誘導体
|
DE3788914T2
(de)
|
1986-09-08 |
1994-08-25 |
Ajinomoto Kk |
Verbindungen zur Spaltung von RNS an eine spezifische Position, Oligomere, verwendet bei der Herstellung dieser Verbindungen und Ausgangsprodukte für die Synthese dieser Oligomere.
|
US5541308A
(en)
|
1986-11-24 |
1996-07-30 |
Gen-Probe Incorporated |
Nucleic acid probes for detection and/or quantitation of non-viral organisms
|
US5276019A
(en)
|
1987-03-25 |
1994-01-04 |
The United States Of America As Represented By The Department Of Health And Human Services |
Inhibitors for replication of retroviruses and for the expression of oncogene products
|
US5264423A
(en)
|
1987-03-25 |
1993-11-23 |
The United States Of America As Represented By The Department Of Health And Human Services |
Inhibitors for replication of retroviruses and for the expression of oncogene products
|
US5229490A
(en)
|
1987-05-06 |
1993-07-20 |
The Rockefeller University |
Multiple antigen peptide system
|
US4904582A
(en)
|
1987-06-11 |
1990-02-27 |
Synthetic Genetics |
Novel amphiphilic nucleic acid conjugates
|
DE3851889T2
(de)
|
1987-06-24 |
1995-04-13 |
Florey Howard Inst |
Nukleosid-derivate.
|
JP3012244B2
(ja)
|
1987-09-21 |
2000-02-21 |
ジェン―プローブ インコーポレイテッド |
ヌクレオチドプローブ用非ヌクレオチド連結試薬
|
US4924624A
(en)
|
1987-10-22 |
1990-05-15 |
Temple University-Of The Commonwealth System Of Higher Education |
2,',5'-phosphorothioate oligoadenylates and plant antiviral uses thereof
|
US5188897A
(en)
|
1987-10-22 |
1993-02-23 |
Temple University Of The Commonwealth System Of Higher Education |
Encapsulated 2',5'-phosphorothioate oligoadenylates
|
ATE151467T1
(de)
|
1987-11-30 |
1997-04-15 |
Univ Iowa Res Found |
Durch modifikationen an der 3'-terminalen phosphodiesterbindung stabilisierte dna moleküle, ihre verwendung als nukleinsäuresonden sowie als therapeutische mittel zur hemmung der expression spezifischer zielgene
|
EP0406309A4
(en)
|
1988-03-25 |
1992-08-19 |
The University Of Virginia Alumni Patents Foundation |
Oligonucleotide n-alkylphosphoramidates
|
US5278302A
(en)
|
1988-05-26 |
1994-01-11 |
University Patents, Inc. |
Polynucleotide phosphorodithioates
|
US5216141A
(en)
|
1988-06-06 |
1993-06-01 |
Benner Steven A |
Oligonucleotide analogs containing sulfur linkages
|
US5262536A
(en)
|
1988-09-15 |
1993-11-16 |
E. I. Du Pont De Nemours And Company |
Reagents for the preparation of 5'-tagged oligonucleotides
|
US5194599A
(en)
|
1988-09-23 |
1993-03-16 |
Gilead Sciences, Inc. |
Hydrogen phosphonodithioate compositions
|
US5457183A
(en)
|
1989-03-06 |
1995-10-10 |
Board Of Regents, The University Of Texas System |
Hydroxylated texaphyrins
|
US5391723A
(en)
|
1989-05-31 |
1995-02-21 |
Neorx Corporation |
Oligonucleotide conjugates
|
US5256775A
(en)
|
1989-06-05 |
1993-10-26 |
Gilead Sciences, Inc. |
Exonuclease-resistant oligonucleotides
|
US4958013A
(en)
|
1989-06-06 |
1990-09-18 |
Northwestern University |
Cholesteryl modified oligonucleotides
|
US5451463A
(en)
|
1989-08-28 |
1995-09-19 |
Clontech Laboratories, Inc. |
Non-nucleoside 1,3-diol reagents for labeling synthetic oligonucleotides
|
US5134066A
(en)
|
1989-08-29 |
1992-07-28 |
Monsanto Company |
Improved probes using nucleosides containing 3-dezauracil analogs
|
US5591722A
(en)
|
1989-09-15 |
1997-01-07 |
Southern Research Institute |
2'-deoxy-4'-thioribonucleosides and their antiviral activity
|
US5721218A
(en)
|
1989-10-23 |
1998-02-24 |
Gilead Sciences, Inc. |
Oligonucleotides with inverted polarity
|
US5399676A
(en)
|
1989-10-23 |
1995-03-21 |
Gilead Sciences |
Oligonucleotides with inverted polarity
|
EP0942000B1
(en)
|
1989-10-24 |
2004-06-23 |
Isis Pharmaceuticals, Inc. |
2'-Modified oligonucleotides
|
US5264564A
(en)
|
1989-10-24 |
1993-11-23 |
Gilead Sciences |
Oligonucleotide analogs with novel linkages
|
US5264562A
(en)
|
1989-10-24 |
1993-11-23 |
Gilead Sciences, Inc. |
Oligonucleotide analogs with novel linkages
|
US5177198A
(en)
|
1989-11-30 |
1993-01-05 |
University Of N.C. At Chapel Hill |
Process for preparing oligoribonucleoside and oligodeoxyribonucleoside boranophosphates
|
US5130302A
(en)
|
1989-12-20 |
1992-07-14 |
Boron Bilogicals, Inc. |
Boronated nucleoside, nucleotide and oligonucleotide compounds, compositions and methods for using same
|
US5486603A
(en)
|
1990-01-08 |
1996-01-23 |
Gilead Sciences, Inc. |
Oligonucleotide having enhanced binding affinity
|
US5670633A
(en)
|
1990-01-11 |
1997-09-23 |
Isis Pharmaceuticals, Inc. |
Sugar modified oligonucleotides that detect and modulate gene expression
|
US5578718A
(en)
|
1990-01-11 |
1996-11-26 |
Isis Pharmaceuticals, Inc. |
Thiol-derivatized nucleosides
|
US5587470A
(en)
|
1990-01-11 |
1996-12-24 |
Isis Pharmaceuticals, Inc. |
3-deazapurines
|
US5587361A
(en)
|
1991-10-15 |
1996-12-24 |
Isis Pharmaceuticals, Inc. |
Oligonucleotides having phosphorothioate linkages of high chiral purity
|
US5459255A
(en)
|
1990-01-11 |
1995-10-17 |
Isis Pharmaceuticals, Inc. |
N-2 substituted purines
|
US5955589A
(en)
|
1991-12-24 |
1999-09-21 |
Isis Pharmaceuticals Inc. |
Gapped 2' modified oligonucleotides
|
US5681941A
(en)
|
1990-01-11 |
1997-10-28 |
Isis Pharmaceuticals, Inc. |
Substituted purines and oligonucleotide cross-linking
|
US5149797A
(en)
|
1990-02-15 |
1992-09-22 |
The Worcester Foundation For Experimental Biology |
Method of site-specific alteration of rna and production of encoded polypeptides
|
US5220007A
(en)
|
1990-02-15 |
1993-06-15 |
The Worcester Foundation For Experimental Biology |
Method of site-specific alteration of RNA and production of encoded polypeptides
|
WO1991013080A1
(en)
|
1990-02-20 |
1991-09-05 |
Gilead Sciences, Inc. |
Pseudonucleosides and pseudonucleotides and their polymers
|
US5214136A
(en)
|
1990-02-20 |
1993-05-25 |
Gilead Sciences, Inc. |
Anthraquinone-derivatives oligonucleotides
|
US5321131A
(en)
|
1990-03-08 |
1994-06-14 |
Hybridon, Inc. |
Site-specific functionalization of oligodeoxynucleotides for non-radioactive labelling
|
US5470967A
(en)
|
1990-04-10 |
1995-11-28 |
The Dupont Merck Pharmaceutical Company |
Oligonucleotide analogs with sulfamate linkages
|
US5264618A
(en)
|
1990-04-19 |
1993-11-23 |
Vical, Inc. |
Cationic lipids for intracellular delivery of biologically active molecules
|
US5688941A
(en)
|
1990-07-27 |
1997-11-18 |
Isis Pharmaceuticals, Inc. |
Methods of making conjugated 4' desmethyl nucleoside analog compounds
|
US5489677A
(en)
|
1990-07-27 |
1996-02-06 |
Isis Pharmaceuticals, Inc. |
Oligonucleoside linkages containing adjacent oxygen and nitrogen atoms
|
US5608046A
(en)
|
1990-07-27 |
1997-03-04 |
Isis Pharmaceuticals, Inc. |
Conjugated 4'-desmethyl nucleoside analog compounds
|
US5677437A
(en)
|
1990-07-27 |
1997-10-14 |
Isis Pharmaceuticals, Inc. |
Heteroatomic oligonucleoside linkages
|
US5623070A
(en)
|
1990-07-27 |
1997-04-22 |
Isis Pharmaceuticals, Inc. |
Heteroatomic oligonucleoside linkages
|
US5602240A
(en)
|
1990-07-27 |
1997-02-11 |
Ciba Geigy Ag. |
Backbone modified oligonucleotide analogs
|
US5138045A
(en)
|
1990-07-27 |
1992-08-11 |
Isis Pharmaceuticals |
Polyamine conjugated oligonucleotides
|
ATE154246T1
(de)
|
1990-07-27 |
1997-06-15 |
Isis Pharmaceuticals Inc |
Nuklease resistente, pyrimidin modifizierte oligonukleotide, die die gen-expression detektieren und modulieren
|
US5618704A
(en)
|
1990-07-27 |
1997-04-08 |
Isis Pharmacueticals, Inc. |
Backbone-modified oligonucleotide analogs and preparation thereof through radical coupling
|
US5541307A
(en)
|
1990-07-27 |
1996-07-30 |
Isis Pharmaceuticals, Inc. |
Backbone modified oligonucleotide analogs and solid phase synthesis thereof
|
US5610289A
(en)
|
1990-07-27 |
1997-03-11 |
Isis Pharmaceuticals, Inc. |
Backbone modified oligonucleotide analogues
|
US5245022A
(en)
|
1990-08-03 |
1993-09-14 |
Sterling Drug, Inc. |
Exonuclease resistant terminally substituted oligonucleotides
|
WO1992002534A2
(en)
|
1990-08-03 |
1992-02-20 |
Sterling Drug, Inc. |
Compounds and methods for inhibiting gene expression
|
US5177196A
(en)
|
1990-08-16 |
1993-01-05 |
Microprobe Corporation |
Oligo (α-arabinofuranosyl nucleotides) and α-arabinofuranosyl precursors thereof
|
US5512667A
(en)
|
1990-08-28 |
1996-04-30 |
Reed; Michael W. |
Trifunctional intermediates for preparing 3'-tailed oligonucleotides
|
US5214134A
(en)
|
1990-09-12 |
1993-05-25 |
Sterling Winthrop Inc. |
Process of linking nucleosides with a siloxane bridge
|
US5561225A
(en)
|
1990-09-19 |
1996-10-01 |
Southern Research Institute |
Polynucleotide analogs containing sulfonate and sulfonamide internucleoside linkages
|
WO1992005186A1
(en)
|
1990-09-20 |
1992-04-02 |
Gilead Sciences |
Modified internucleoside linkages
|
US5432272A
(en)
|
1990-10-09 |
1995-07-11 |
Benner; Steven A. |
Method for incorporating into a DNA or RNA oligonucleotide using nucleotides bearing heterocyclic bases
|
US5672697A
(en)
|
1991-02-08 |
1997-09-30 |
Gilead Sciences, Inc. |
Nucleoside 5'-methylene phosphonates
|
US5539082A
(en)
|
1993-04-26 |
1996-07-23 |
Nielsen; Peter E. |
Peptide nucleic acids
|
FR2677272B1
(fr)
|
1991-06-05 |
1995-03-03 |
Biovecteurs As |
Vecteur particulaire a tropisme selectif, procede de preparation et composition pharmaceutique.
|
US5371241A
(en)
|
1991-07-19 |
1994-12-06 |
Pharmacia P-L Biochemicals Inc. |
Fluorescein labelled phosphoramidites
|
US5571799A
(en)
|
1991-08-12 |
1996-11-05 |
Basco, Ltd. |
(2'-5') oligoadenylate analogues useful as inhibitors of host-v5.-graft response
|
EP0538194B1
(de)
|
1991-10-17 |
1997-06-04 |
Novartis AG |
Bicyclische Nukleoside, Oligonukleotide, Verfahren zu deren Herstellung und Zwischenprodukte
|
ATE239484T1
(de)
|
1991-10-24 |
2003-05-15 |
Isis Pharmaceuticals Inc |
Derivatisierte oligonukleotide mit verbessertem aufnahmevermögen
|
US5594121A
(en)
|
1991-11-07 |
1997-01-14 |
Gilead Sciences, Inc. |
Enhanced triple-helix and double-helix formation with oligomers containing modified purines
|
US5484908A
(en)
|
1991-11-26 |
1996-01-16 |
Gilead Sciences, Inc. |
Oligonucleotides containing 5-propynyl pyrimidines
|
TW393513B
(en)
|
1991-11-26 |
2000-06-11 |
Isis Pharmaceuticals Inc |
Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines
|
US5792608A
(en)
|
1991-12-12 |
1998-08-11 |
Gilead Sciences, Inc. |
Nuclease stable and binding competent oligomers and methods for their use
|
US5359044A
(en)
|
1991-12-13 |
1994-10-25 |
Isis Pharmaceuticals |
Cyclobutyl oligonucleotide surrogates
|
US5700922A
(en)
|
1991-12-24 |
1997-12-23 |
Isis Pharmaceuticals, Inc. |
PNA-DNA-PNA chimeric macromolecules
|
FR2687679B1
(fr)
|
1992-02-05 |
1994-10-28 |
Centre Nat Rech Scient |
Oligothionucleotides.
|
US5814666A
(en)
|
1992-04-13 |
1998-09-29 |
The United States As Represented By The Department Of Health And Human Services |
Encapsulated and non-encapsulated nitric oxide generators used as antimicrobial agents
|
US5633360A
(en)
|
1992-04-14 |
1997-05-27 |
Gilead Sciences, Inc. |
Oligonucleotide analogs capable of passive cell membrane permeation
|
JPH07508342A
(ja)
|
1992-04-22 |
1995-09-14 |
エコール ポリテクニーク フェデラル ドゥ ローザンヌ(エーペーエフエル) |
脂質膜センサー
|
US5434257A
(en)
|
1992-06-01 |
1995-07-18 |
Gilead Sciences, Inc. |
Binding compentent oligomers containing unsaturated 3',5' and 2',5' linkages
|
EP0577558A2
(de)
|
1992-07-01 |
1994-01-05 |
Ciba-Geigy Ag |
Carbocyclische Nukleoside mit bicyclischen Ringen, Oligonukleotide daraus, Verfahren zu deren Herstellung, deren Verwendung und Zwischenproduckte
|
HUT69981A
(en)
|
1992-07-02 |
1995-09-28 |
Hybridon Inc |
Self-stabilized oligonucleotides as therapeutic agents
|
US5652355A
(en)
|
1992-07-23 |
1997-07-29 |
Worcester Foundation For Experimental Biology |
Hybrid oligonucleotide phosphorothioates
|
US5476925A
(en)
|
1993-02-01 |
1995-12-19 |
Northwestern University |
Oligodeoxyribonucleotides including 3'-aminonucleoside-phosphoramidate linkages and terminal 3'-amino groups
|
GB9304618D0
(en)
|
1993-03-06 |
1993-04-21 |
Ciba Geigy Ag |
Chemical compounds
|
EP0691968B1
(en)
|
1993-03-30 |
1997-07-16 |
Sanofi |
Acyclic nucleoside analogs and oligonucleotide sequences containing them
|
EP0691977B1
(en)
|
1993-03-31 |
1997-11-26 |
Sanofi |
Oligonucleotides with amide linkages replacing phosphodiester linkages
|
DE4311944A1
(de)
|
1993-04-10 |
1994-10-13 |
Degussa |
Umhüllte Natriumpercarbonatpartikel, Verfahren zu deren Herstellung und sie enthaltende Wasch-, Reinigungs- und Bleichmittelzusammensetzungen
|
DK0748382T3
(da)
|
1993-09-02 |
2003-02-17 |
Ribozyme Pharm Inc |
Enzymatisk nukleinsyre indeholdende ikke-nukleotid
|
US5502177A
(en)
|
1993-09-17 |
1996-03-26 |
Gilead Sciences, Inc. |
Pyrimidine derivatives for labeled binding partners
|
US5457187A
(en)
|
1993-12-08 |
1995-10-10 |
Board Of Regents University Of Nebraska |
Oligonucleotides containing 5-fluorouracil
|
DE69425903T2
(de)
|
1993-12-09 |
2001-02-15 |
Thomas Jefferson University Ph |
Verbindungen und verfahren zur ortsspezifischen mutation in eukaryotischen zellen
|
US5446137B1
(en)
|
1993-12-09 |
1998-10-06 |
Behringwerke Ag |
Oligonucleotides containing 4'-substituted nucleotides
|
US5519134A
(en)
|
1994-01-11 |
1996-05-21 |
Isis Pharmaceuticals, Inc. |
Pyrrolidine-containing monomers and oligomers
|
US5596091A
(en)
|
1994-03-18 |
1997-01-21 |
The Regents Of The University Of California |
Antisense oligonucleotides comprising 5-aminoalkyl pyrimidine nucleotides
|
US5627053A
(en)
|
1994-03-29 |
1997-05-06 |
Ribozyme Pharmaceuticals, Inc. |
2'deoxy-2'-alkylnucleotide containing nucleic acid
|
US5625050A
(en)
|
1994-03-31 |
1997-04-29 |
Amgen Inc. |
Modified oligonucleotides and intermediates useful in nucleic acid therapeutics
|
US5646269A
(en)
|
1994-04-28 |
1997-07-08 |
Gilead Sciences, Inc. |
Method for oligonucleotide analog synthesis
|
US5525711A
(en)
|
1994-05-18 |
1996-06-11 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Pteridine nucleotide analogs as fluorescent DNA probes
|
US20030026782A1
(en)
|
1995-02-07 |
2003-02-06 |
Arthur M. Krieg |
Immunomodulatory oligonucleotides
|
CA2560114A1
(en)
|
1994-07-15 |
1996-02-01 |
The University Of Iowa Research Foundation |
Immunomodulatory oligonucleotides
|
US6429199B1
(en)
|
1994-07-15 |
2002-08-06 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules for activating dendritic cells
|
US6239116B1
(en)
|
1994-07-15 |
2001-05-29 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
US6207646B1
(en)
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
US5597909A
(en)
|
1994-08-25 |
1997-01-28 |
Chiron Corporation |
Polynucleotide reagents containing modified deoxyribose moieties, and associated methods of synthesis and use
|
EP0824541B1
(en)
|
1995-05-04 |
2009-12-16 |
Gilead Sciences, Inc. |
Nucleic acid ligand complexes
|
US5912340A
(en)
|
1995-10-04 |
1999-06-15 |
Epoch Pharmaceuticals, Inc. |
Selective binding complementary oligonucleotides
|
US5780448A
(en)
|
1995-11-07 |
1998-07-14 |
Ottawa Civic Hospital Loeb Research |
DNA-based vaccination of fish
|
WO1997048715A1
(en)
|
1996-06-19 |
1997-12-24 |
Hybridon, Inc. |
Modulation of tetraplex formation by chemical modifications of a g4-containing oligonucleotide
|
US6750016B2
(en)
|
1996-07-29 |
2004-06-15 |
Nanosphere, Inc. |
Nanoparticles having oligonucleotides attached thereto and uses therefor
|
US20020172953A1
(en)
|
1996-07-29 |
2002-11-21 |
Mirkin Chad A. |
Movement of biomolecule-coated nanoparticles in an electric field
|
US6582921B2
(en)
|
1996-07-29 |
2003-06-24 |
Nanosphere, Inc. |
Nanoparticles having oligonucleotides attached thereto and uses thereof
|
US7098320B1
(en)
|
1996-07-29 |
2006-08-29 |
Nanosphere, Inc. |
Nanoparticles having oligonucleotides attached thereto and uses therefor
|
ES2287956T3
(es)
|
1996-07-29 |
2007-12-16 |
Nanosphere Inc. |
Nanoparticulas que tienen oligonucleotidos unidos a las mismas y usos de las mismas.
|
US6506564B1
(en)
|
1996-07-29 |
2003-01-14 |
Nanosphere, Inc. |
Nanoparticles having oligonucleotides attached thereto and uses therefor
|
US6361944B1
(en)
|
1996-07-29 |
2002-03-26 |
Nanosphere, Inc. |
Nanoparticles having oligonucleotides attached thereto and uses therefor
|
US5849902A
(en)
|
1996-09-26 |
1998-12-15 |
Oligos Etc. Inc. |
Three component chimeric antisense oligonucleotides
|
US6056973A
(en)
|
1996-10-11 |
2000-05-02 |
Sequus Pharmaceuticals, Inc. |
Therapeutic liposome composition and method of preparation
|
US20060002949A1
(en)
|
1996-11-14 |
2006-01-05 |
Army Govt. Of The Usa, As Rep. By Secretary Of The Office Of The Command Judge Advocate, Hq Usamrmc. |
Transcutaneous immunization without heterologous adjuvant
|
EP0856579A1
(en)
|
1997-01-31 |
1998-08-05 |
BIOGNOSTIK GESELLSCHAFT FÜR BIOMOLEKULARE DIAGNOSTIK mbH |
An antisense oligonucleotide preparation method
|
WO1998037919A1
(en)
|
1997-02-28 |
1998-09-03 |
University Of Iowa Research Foundation |
USE OF NUCLEIC ACIDS CONTAINING UNMETHYLATED CpG DINUCLEOTIDE IN THE TREATMENT OF LPS-ASSOCIATED DISORDERS
|
JP3756313B2
(ja)
|
1997-03-07 |
2006-03-15 |
武 今西 |
新規ビシクロヌクレオシド及びオリゴヌクレオチド類縁体
|
US6406705B1
(en)
|
1997-03-10 |
2002-06-18 |
University Of Iowa Research Foundation |
Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
|
US6426334B1
(en)
|
1997-04-30 |
2002-07-30 |
Hybridon, Inc. |
Oligonucleotide mediated specific cytokine induction and reduction of tumor growth in a mammal
|
US20030104044A1
(en)
|
1997-05-14 |
2003-06-05 |
Semple Sean C. |
Compositions for stimulating cytokine secretion and inducing an immune response
|
CA2301575C
(en)
|
1997-05-20 |
2003-12-23 |
Ottawa Civic Hospital Loeb Research Institute |
Vectors and methods for immunization or therapeutic protocols
|
CA2303299C
(en)
|
1997-09-12 |
2016-02-23 |
Exiqon A/S |
Oligonucleotide analogues
|
US6271209B1
(en)
|
1998-04-03 |
2001-08-07 |
Valentis, Inc. |
Cationic lipid formulation delivering nucleic acid to peritoneal tumors
|
US6218371B1
(en)
|
1998-04-03 |
2001-04-17 |
University Of Iowa Research Foundation |
Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines
|
US6287765B1
(en)
|
1998-05-20 |
2001-09-11 |
Molecular Machines, Inc. |
Methods for detecting and identifying single molecules
|
IL139813A0
(en)
|
1998-05-22 |
2002-02-10 |
Loeb Health Res Inst At The Ot |
Methods and products for inducing mucosal immunity
|
US6562798B1
(en)
|
1998-06-05 |
2003-05-13 |
Dynavax Technologies Corp. |
Immunostimulatory oligonucleotides with modified bases and methods of use thereof
|
CA2248592A1
(en)
|
1998-08-31 |
2000-02-29 |
Christopher D. Batich |
Microspheres for use in the treatment of cancer
|
FR2783170B1
(fr)
|
1998-09-11 |
2004-07-16 |
Pasteur Merieux Serums Vacc |
Emulsion immunostimulante
|
US6228642B1
(en)
|
1998-10-05 |
2001-05-08 |
Isis Pharmaceuticals, Inc. |
Antisense oligonucleotide modulation of tumor necrosis factor-(α) (TNF-α) expression
|
US6194328B1
(en)
|
1998-12-09 |
2001-02-27 |
Advanced Micro Devices, Inc. |
H2 diffusion barrier formation by nitrogen incorporation in oxide layer
|
EP1141297B1
(en)
|
1999-01-11 |
2009-09-30 |
Schering Corporation |
Interleukin-17 related mammalian cytokines. polynucleotides encoding them . uses
|
EP1053751A1
(en)
|
1999-05-17 |
2000-11-22 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Compositions and methods for treating cell proliferation disorders
|
US6656730B1
(en)
|
1999-06-15 |
2003-12-02 |
Isis Pharmaceuticals, Inc. |
Oligonucleotides conjugated to protein-binding drugs
|
DE60045739D1
(de)
|
1999-06-25 |
2011-04-28 |
Nanosphere Inc |
Nanopartikel mit gebundenen oligonukleotiden und deren verwendungen
|
ATE427751T1
(de)
|
1999-07-08 |
2009-04-15 |
Cap Biotechnology Inc |
Calcium-enthaltende strukture und verfahren zur herstellung und verwendung davon
|
DE19935756A1
(de)
|
1999-07-27 |
2001-02-08 |
Mologen Forschungs Entwicklung |
Kovalent geschlossenes Nukleinsäuremolekül zur Immunstimulation
|
WO2001012223A2
(en)
|
1999-08-19 |
2001-02-22 |
Dynavax Technologies Corporation |
Methods of modulating an immune response using immunostimulatory sequences and compositions for use therein
|
NZ517929A
(en)
|
1999-09-25 |
2004-02-27 |
Univ Iowa Res Found |
Immunostimulatory nucleic acids
|
JP2003510290A
(ja)
|
1999-09-27 |
2003-03-18 |
コーリー ファーマシューティカル グループ,インコーポレイテッド |
免疫刺激核酸誘導インターフェロンに関する方法
|
US6949520B1
(en)
|
1999-09-27 |
2005-09-27 |
Coley Pharmaceutical Group, Inc. |
Methods related to immunostimulatory nucleic acid-induced interferon
|
US6585947B1
(en)
|
1999-10-22 |
2003-07-01 |
The Board Of Trustess Of The University Of Illinois |
Method for producing silicon nanoparticles
|
US7223398B1
(en)
|
1999-11-15 |
2007-05-29 |
Dynavax Technologies Corporation |
Immunomodulatory compositions containing an immunostimulatory sequence linked to antigen and methods of use thereof
|
ATE393221T1
(de)
|
1999-11-29 |
2008-05-15 |
Avi Biopharma Inc |
Gegen bakterielle 16s und 23s rrnas gerichtete ungeladene antisense oligonukleotide und deren verwendungen
|
US20030181412A1
(en)
|
1999-12-21 |
2003-09-25 |
Ingeneus Corporation |
Method for modifying transcription and/or translation in an organism for therapeutic, prophylactic and/or analytic uses
|
WO2001049869A1
(fr)
|
1999-12-30 |
2001-07-12 |
Aventis Pharma S.A. |
Compositions comprenant des acides nucleiques incorpores dans des particules minerales bilamellaires
|
JP2004501340A
(ja)
|
2000-01-13 |
2004-01-15 |
ナノスフェアー インコーポレイテッド |
オリゴヌクレオチドを付着させたナノ粒子とその使用方法
|
AT409085B
(de)
|
2000-01-28 |
2002-05-27 |
Cistem Biotechnologies Gmbh |
Pharmazeutische zusammensetzung zur immunmodulation und herstellung von vakzinen
|
US7491805B2
(en)
|
2001-05-18 |
2009-02-17 |
Sirna Therapeutics, Inc. |
Conjugates and compositions for cellular delivery
|
US7833992B2
(en)
|
2001-05-18 |
2010-11-16 |
Merck Sharpe & Dohme |
Conjugates and compositions for cellular delivery
|
US20020156033A1
(en)
|
2000-03-03 |
2002-10-24 |
Bratzler Robert L. |
Immunostimulatory nucleic acids and cancer medicament combination therapy for the treatment of cancer
|
US20040131628A1
(en)
|
2000-03-08 |
2004-07-08 |
Bratzler Robert L. |
Nucleic acids for the treatment of disorders associated with microorganisms
|
US20030129251A1
(en)
|
2000-03-10 |
2003-07-10 |
Gary Van Nest |
Biodegradable immunomodulatory formulations and methods for use thereof
|
US7129222B2
(en)
|
2000-03-10 |
2006-10-31 |
Dynavax Technologies Corporation |
Immunomodulatory formulations and methods for use thereof
|
JP2004515208A
(ja)
|
2000-03-28 |
2004-05-27 |
ナノスフェアー インコーポレイテッド |
オリゴヌクレオチドを付着させたナノ粒子とその使用方法
|
WO2001072123A1
(en)
|
2000-03-28 |
2001-10-04 |
The Regents Of The University Of California |
Methods for increasing a cytotoxic t lymphocyte response in vivo
|
EP2292632A3
(en)
|
2000-09-26 |
2012-07-25 |
Idera Pharmaceuticals, Inc. |
Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
|
ATE510847T1
(de)
|
2000-11-20 |
2011-06-15 |
Univ Illinois |
Membrangerüstproteine
|
US7083958B2
(en)
|
2000-11-20 |
2006-08-01 |
The Board Of Trustees Of The University Of Illinois |
Membrane scaffold proteins
|
CZ308053B6
(cs)
|
2000-12-01 |
2019-11-27 |
Max Planck Gesellschaft |
Izolovaná molekula dvouřetězcové RNA, způsob její výroby a její použití
|
ES2307568T3
(es)
|
2000-12-08 |
2008-12-01 |
Coley Pharmaceutical Gmbh |
Acidos nucleicos de tipo cpg y metodos de uso de los mismos.
|
DE10065475A1
(de)
|
2000-12-28 |
2002-07-18 |
Switch Biotech Ag |
Verwendung von "intermediate-conductance" Kaliumkanälen und Modulatoren zur Diagnose und Behandlung von Krankheiten mit gestörter Keratinozytenfunktion
|
US7563618B2
(en)
|
2001-03-23 |
2009-07-21 |
Geron Corporation |
Oligonucleotide conjugates
|
US7176296B2
(en)
|
2001-04-30 |
2007-02-13 |
Idera Pharmaceuticals, Inc. |
Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosides
|
GB0111279D0
(en)
|
2001-05-10 |
2001-06-27 |
Nycomed Imaging As |
Radiolabelled liposomes
|
US20060019917A1
(en)
|
2001-05-18 |
2006-01-26 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of stromal cell-derived factor-1 (SDF-1) gene expression using short interfering nucleic acid (siNA)
|
US7238472B2
(en)
|
2001-05-25 |
2007-07-03 |
Nanosphere, Inc. |
Non-alloying core shell nanoparticles
|
RU2294192C2
(ru)
|
2001-05-30 |
2007-02-27 |
Дзе Скриппс Рисерч Инститьют |
Система доставки нуклеиновых кислот
|
PT1404873E
(pt)
|
2001-06-21 |
2013-07-30 |
Dynavax Tech Corp |
Compostos de imunomodulação quiméricos e métodos de utilização dos mesmos
|
AU2002364927A1
(en)
|
2001-07-10 |
2003-06-30 |
North Carolina State University |
Nanoparticle delivery vehicle
|
US7666674B2
(en)
|
2001-07-27 |
2010-02-23 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Use of sterically stabilized cationic liposomes to efficiently deliver CPG oligonucleotides in vivo
|
JP4607452B2
(ja)
|
2001-08-07 |
2011-01-05 |
ダイナバックス テクノロジーズ コーポレイション |
免疫調節性組成物、製剤およびその使用方法
|
EP1450856B1
(en)
|
2001-09-14 |
2009-11-11 |
Cytos Biotechnology AG |
Packaging of immunostimulatory cpg into virus-like particles: method of preparation and use
|
US20030134810A1
(en)
|
2001-10-09 |
2003-07-17 |
Chris Springate |
Methods and compositions comprising biocompatible materials useful for the administration of therapeutic agents
|
US7276489B2
(en)
|
2002-10-24 |
2007-10-02 |
Idera Pharmaceuticals, Inc. |
Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends
|
TW200303759A
(en)
|
2001-11-27 |
2003-09-16 |
Schering Corp |
Methods for treating cancer
|
JP2005515780A
(ja)
|
2002-02-01 |
2005-06-02 |
セクイター インコーポレイテッド |
二本鎖オリゴヌクレオチド
|
US8088388B2
(en)
|
2002-02-14 |
2012-01-03 |
United Biomedical, Inc. |
Stabilized synthetic immunogen delivery system
|
CA2480775C
(en)
|
2002-04-04 |
2016-05-31 |
Coley Pharmaceutical Gmbh |
Immunostimulatory g,u-containing oligoribonucleotides
|
US20040038303A1
(en)
|
2002-04-08 |
2004-02-26 |
Unger Gretchen M. |
Biologic modulations with nanoparticles
|
CA2388049A1
(en)
|
2002-05-30 |
2003-11-30 |
Immunotech S.A. |
Immunostimulatory oligonucleotides and uses thereof
|
DE60333365D1
(de)
|
2002-05-30 |
2010-08-26 |
Sloan Kettering Inst Cancer |
Kinasesuppressor der ras-inaktivierung zur therapie von durch ras vermittelter tumorgenese
|
US7569553B2
(en)
|
2002-07-03 |
2009-08-04 |
Coley Pharmaceutical Group, Inc. |
Nucleic acid compositions for stimulating immune responses
|
WO2004014322A2
(en)
|
2002-08-12 |
2004-02-19 |
Dynavax Technologies Corporation |
Immunomodulatory compositions, methods of making, and methods of use thereof
|
AR040996A1
(es)
|
2002-08-19 |
2005-04-27 |
Coley Pharm Group Inc |
Acidos nucleicos inmunoestimuladores
|
CN1753687A
(zh)
|
2002-10-29 |
2006-03-29 |
科勒制药集团股份有限公司 |
Cpg寡核苷酸在治疗丙型肝炎病毒感染中的应用
|
GB0227738D0
(en)
|
2002-11-28 |
2003-01-08 |
Univ Liverpool |
Nanoparticle conjugates and method of production thereof
|
US8158768B2
(en)
|
2002-12-23 |
2012-04-17 |
Dynavax Technologies Corporation |
Immunostimulatory sequence oligonucleotides and methods of using the same
|
CN100546998C
(zh)
|
2002-12-23 |
2009-10-07 |
戴纳伐克斯技术股份有限公司 |
免疫刺激序列寡核苷酸和使用方法
|
EP2572715A1
(en)
|
2002-12-30 |
2013-03-27 |
3M Innovative Properties Company |
Immunostimulatory Combinations
|
US20060105343A1
(en)
|
2003-01-09 |
2006-05-18 |
Children's Medical Center Corporation |
Methods for diagnosis and prognosis of cancer
|
AU2004206820B2
(en)
|
2003-01-16 |
2010-06-10 |
Idera Pharmaceuticals, Inc. |
Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides
|
US7354907B2
(en)
|
2003-02-07 |
2008-04-08 |
Idera Pharmaceuticals, Inc. |
Short immunomodulatory oligonucleotides
|
JP2004315433A
(ja)
|
2003-04-16 |
2004-11-11 |
Woong-Shick Ahn |
乳頭腫ウィルス抗原蛋白質及びCpG−オリゴデオキシヌクレオチドを含む乳頭腫ウィルス誘発疾患の予防又は治療用薬剤学的組成物
|
US7569554B2
(en)
|
2003-05-16 |
2009-08-04 |
Idera Pharmaceuticals, Inc. |
Synergistic treatment of cancer using immunomers in conjunction with therapeutic agents
|
US7727969B2
(en)
|
2003-06-06 |
2010-06-01 |
Massachusetts Institute Of Technology |
Controlled release nanoparticle having bound oligonucleotide for targeted delivery
|
KR101137572B1
(ko)
|
2003-06-11 |
2012-05-30 |
이데라 파마슈티칼즈, 인코포레이티드 |
안정화된 면역조절 올리고뉴클레오티드
|
US20050096263A1
(en)
|
2003-10-30 |
2005-05-05 |
Keay Susan K. |
Novel antiproliferative factor and methods of use
|
US20060251623A1
(en)
|
2003-07-10 |
2006-11-09 |
Caytos Biotechnology Ag |
Packaged virus-like particles
|
MXPA06000619A
(es)
|
2003-07-15 |
2006-04-11 |
Hybridon Inc |
Estimulacion sinergistica del sistema inmune usando oligonucleotidos inmunoestimuladores y/o compuestos inmunomeros en conjunto con citocinas y/o agentes quimioterapeuticos o terapia de radiacion.
|
US20080057128A1
(en)
|
2003-07-18 |
2008-03-06 |
Omeros Corporation |
Biodegradable triblock copolymers, synthesis methods therefore, and hydrogels and biomaterials made there from
|
ES2662196T3
(es)
|
2003-09-09 |
2018-04-05 |
Geron Corporation |
Oligonucleótidos modificados para la inhibición de la telomerasa
|
US7615539B2
(en)
|
2003-09-25 |
2009-11-10 |
Coley Pharmaceutical Group, Inc. |
Nucleic acid-lipophilic conjugates
|
US6979738B2
(en)
|
2003-10-22 |
2005-12-27 |
Academia Sinica |
Quadruplex stabilizer
|
SG122973A1
(en)
|
2003-10-30 |
2006-06-29 |
Coley Pharm Gmbh |
C-class oligonucleotide analogs with enhanced immunostimulatory potency
|
AU2004304770B2
(en)
|
2003-12-08 |
2010-05-06 |
Idera Pharmaceuticals, Inc. |
Modulation of immunostimulatory properties by small oligonucleotide-based compounds
|
US7846412B2
(en)
|
2003-12-22 |
2010-12-07 |
Emory University |
Bioconjugated nanostructures, methods of fabrication thereof, and methods of use thereof
|
EP1550458A1
(en)
*
|
2003-12-23 |
2005-07-06 |
Vectron Therapeutics AG |
Synergistic liposomal adjuvants
|
EP1547581A1
(en)
*
|
2003-12-23 |
2005-06-29 |
Vectron Therapeutics AG |
Liposomal vaccine for the treatment of human hematological malignancies
|
CN1918293A
(zh)
|
2004-02-20 |
2007-02-21 |
莫洛根股份公司 |
用于对人及高等动物进行治疗性和预防性免疫刺激的取代的非编码核酸分子
|
JP2007525500A
(ja)
|
2004-02-26 |
2007-09-06 |
レイヤーラボ・アクテイエボラーグ |
脂質膜への付着に関係するオリゴヌクレオチド
|
US20060019916A1
(en)
|
2004-04-02 |
2006-01-26 |
Coley Pharmaceutical Group, Inc. |
Immunostimulatory nucleic acids for inducing IL-10 responses
|
US20080274454A1
(en)
|
2004-04-07 |
2008-11-06 |
Mirkin Chad A |
Reversible and Chemically Programmable Micelle Assembly With Dna Block-Copolymer Amphiphiles
|
GB0409940D0
(en)
|
2004-05-04 |
2004-06-09 |
Glaxosmithkline Biolog Sa |
Vaccine
|
WO2005116226A2
(en)
|
2004-05-24 |
2005-12-08 |
Midatech Ltd |
Nanoparticles comprising rna ligands
|
GB0411537D0
(en)
|
2004-05-24 |
2004-06-23 |
Midatech Ltd |
Nanoparticles comprising rna ligands
|
AU2005287383B2
(en)
|
2004-05-25 |
2011-09-22 |
Chimeros, Inc. |
Self-assembling nanoparticle drug delivery system
|
EP1753453A2
(en)
|
2004-06-08 |
2007-02-21 |
Coley Pharmaceutical GmbH |
Abasic oligonucleotide as carrier platform for antigen and immunostimulatory agonist and antagonist
|
EP1604669A1
(en)
|
2004-06-10 |
2005-12-14 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Use of ATP analogues for treatment of cardiovascular diseases
|
WO2006002038A2
(en)
|
2004-06-15 |
2006-01-05 |
Hybridon, Inc. |
Immunostimulatory oligonucleotide multimers
|
US7427405B2
(en)
|
2004-06-15 |
2008-09-23 |
Idera Pharmaceuticals, Inc. |
Immunostimulatory oligonucleotide multimers
|
ATE511859T1
(de)
|
2004-07-20 |
2011-06-15 |
Schering Corp |
Apoptoseinduktion in toll-artige rezeptoren exprimierenden tumorzellen
|
WO2006012695A1
(en)
|
2004-08-04 |
2006-02-09 |
Panvax Limited |
An immunogenic composition
|
WO2006015560A1
(de)
|
2004-08-09 |
2006-02-16 |
Mologen Ag |
Immunmodulierendes mittel in verbindung mit chemotherapeutischen massnahmen
|
WO2006044660A2
(en)
|
2004-10-14 |
2006-04-27 |
Vanderbilt University |
Functionalized solid lipid nanoparticles and methods of making and using same
|
MY159370A
(en)
|
2004-10-20 |
2016-12-30 |
Coley Pharm Group Inc |
Semi-soft-class immunostimulatory oligonucleotides
|
KR100721928B1
(ko)
|
2004-11-05 |
2007-05-28 |
주식회사 바이오씨에스 |
CpG 올리고데옥시뉴클레오티드를 함유하는 피부질환의치료 또는 예방용 약학적 조성물
|
CA2586913A1
(en)
|
2004-11-09 |
2006-05-18 |
University Of Southern California |
Targeted innate immunity
|
US20080003232A1
(en)
|
2004-11-29 |
2008-01-03 |
Liying Wang |
Cpg Single Strand Deoxynucleotides for Use as Adjuvant
|
US7404969B2
(en)
|
2005-02-14 |
2008-07-29 |
Sirna Therapeutics, Inc. |
Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules
|
RU2007129263A
(ru)
|
2005-02-14 |
2009-03-20 |
Вайет (Us) |
Антитела к интерлейкину-17f и другие антагонисты опосредуемой il-17f передачи сигналов и их применение
|
CA2597724A1
(en)
|
2005-02-14 |
2007-08-02 |
Sirna Therapeutics, Inc. |
Cationic lipids and formulated molecular compositions containing them
|
SG160336A1
(en)
|
2005-03-04 |
2010-04-29 |
Dynavax Tech Corp |
Vaccines comprising oligonucleotides having immunostimulatory sequences (iss) wherein the iss are conjugated to antigens and stabilized by buffer conditions and further excipients
|
US20070065359A1
(en)
|
2005-03-14 |
2007-03-22 |
Shiladitya Sengupta |
Nanocells for diagnosis and treatment of diseases and disorders
|
US8211712B2
(en)
|
2005-03-29 |
2012-07-03 |
The Board Of Trustees Of The Leland Stanford Junior University |
Method of fabricating lipid bilayer membranes on solid supports
|
DE102005016873A1
(de)
|
2005-04-12 |
2006-10-19 |
Magforce Nanotechnologies Ag |
Nanopartikel-Wirstoff-Konjugate
|
US8246995B2
(en)
|
2005-05-10 |
2012-08-21 |
The Board Of Trustees Of The Leland Stanford Junior University |
Hydrophobic nanotubes and nanoparticles as transporters for the delivery of drugs into cells
|
WO2006124089A1
(en)
|
2005-05-12 |
2006-11-23 |
The Arizona Board Of Regents, A Body Corporate Acting On Behalf Of Arizona State University |
Self-assembled nucleic acid nanoarrays and uses therefor
|
US20090214618A1
(en)
|
2005-05-27 |
2009-08-27 |
Schoenfisch Mark H |
Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications
|
WO2006138145A1
(en)
|
2005-06-14 |
2006-12-28 |
Northwestern University |
Nucleic acid functionalized nanoparticles for therapeutic applications
|
SG163583A1
(en)
|
2005-07-07 |
2010-08-30 |
Coley Pharm Group Inc |
Anti-ctla-4 antibody and cpg-motif-containing synthetic oligodeoxynucleotide combination therapy for cancer treatment
|
US8067571B2
(en)
|
2005-07-13 |
2011-11-29 |
Avi Biopharma, Inc. |
Antibacterial antisense oligonucleotide and method
|
AU2006284889B2
(en)
|
2005-08-31 |
2011-08-18 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Methods of altering an immune response induced by CpG oligodeoxynucleotides
|
WO2007047455A2
(en)
|
2005-10-13 |
2007-04-26 |
Northwestern University |
Colorimetric screening of dna binding/intercalating agents with gold nanoparticle probes
|
US20070093439A1
(en)
|
2005-10-25 |
2007-04-26 |
Idera Pharmaceuticals, Inc. |
Short immunomodulatory oligonucleotides
|
FR2892819B1
(fr)
|
2005-10-28 |
2008-02-01 |
Centre Nat Rech Scient |
Nanoparticules a luminescence persistance pour leur utilisation en tant qu'agent de diagnostic destine a l'imagerie optique in vivo
|
US7470674B2
(en)
|
2005-11-07 |
2008-12-30 |
Idera Pharmaceuticals, Inc. |
Immunostimulatory properties of oligonucleotide-based compounds comprising modified immunostimulatory dinucleotides
|
EP1945653A4
(en)
|
2005-11-07 |
2012-03-14 |
Idera Pharmaceuticals |
IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS COMPRISING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
|
AU2005338035B2
(en)
|
2005-11-07 |
2012-06-07 |
Idera Pharmaceuticals, Inc. |
Immunostimulatory properties of oligonucleotide-based compounds comprising modified immunostimulatory dinucleotides
|
US7776834B2
(en)
|
2005-11-07 |
2010-08-17 |
Idera Pharmaceuticals, Inc. |
Immunostimulatory properties of oligonucleotide-based compounds comprising modified immunostimulatory dinucleotides
|
GB2448255A
(en)
|
2005-12-01 |
2008-10-08 |
Trinity College Dublin |
Compositions and methods relating to treatment of cancer and infectious diseases
|
ES2419106T3
(es)
|
2005-12-01 |
2013-08-19 |
Pronai Therapeutics, Inc. |
Formulación de liposomas anfóteros
|
US20090317802A1
(en)
|
2005-12-09 |
2009-12-24 |
Bhatia Sangeeta N |
Compositions and Methods to Monitor RNA Delivery to Cells
|
AU2006325225B2
(en)
|
2005-12-14 |
2013-07-04 |
Cytos Biotechnology Ag |
Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity
|
AU2006336242A1
(en)
|
2005-12-20 |
2007-07-26 |
Idera Pharmaceuticals, Inc. |
Novel synthetic agonists of toll-like receptors containing CG dinucleotide modifications
|
CN101379195B
(zh)
|
2005-12-20 |
2012-05-09 |
艾德拉药物股份有限公司 |
含有不同长度回文片段的回文免疫调节性寡核苷酸(imotm)的免疫刺激活性
|
EP1978997A1
(en)
|
2005-12-22 |
2008-10-15 |
Apollo Life Sciences Limited |
Transdermal delivery of pharmaceutical agents
|
US20070148251A1
(en)
|
2005-12-22 |
2007-06-28 |
Hossainy Syed F A |
Nanoparticle releasing medical devices
|
CA2636424A1
(en)
|
2006-01-09 |
2007-10-25 |
The Regents Of The University Of California |
Immunostimulatory combinations of tnfrsf, tlr, nlr, rhr, purinergic receptor, and cytokine receptor agonists for vaccines and tumor immunotherapy
|
JP2009524430A
(ja)
|
2006-01-26 |
2009-07-02 |
ユニバーシティ オブ マサチューセッツ |
治療的使用のためのrna干渉剤
|
US7723045B2
(en)
|
2006-02-10 |
2010-05-25 |
The Regents Of The University Of California |
Assays to predict atherosclerosis and dysfunctional high-density lipoprotein
|
ES2553284T5
(es)
|
2006-02-15 |
2021-08-31 |
Rechtsanwalt Thomas Beck |
Composiciones y procedimientos para formulaciones de oligonucleótidos
|
EP1820804A1
(en)
|
2006-02-20 |
2007-08-22 |
Humboldt-Universität zu Berlin |
Lipidated oligonucleotides
|
US8361494B2
(en)
|
2006-03-10 |
2013-01-29 |
The Trustees Of The University Of Pennsylvania |
Biomimetic iron-oxide-containing lipoprotein and related materials
|
EP2012772A1
(en)
|
2006-04-26 |
2009-01-14 |
The Uab Research Foundation |
Reducing cancer cell invasion using an inhibitor of toll like receptor signaling
|
KR20090012265A
(ko)
|
2006-05-11 |
2009-02-02 |
몰로겐 아게 |
면역자극용 멀티머
|
US20110052697A1
(en)
|
2006-05-17 |
2011-03-03 |
Gwangju Institute Of Science & Technology |
Aptamer-Directed Drug Delivery
|
US9506056B2
(en)
|
2006-06-08 |
2016-11-29 |
Northwestern University |
Nucleic acid functionalized nanoparticles for therapeutic applications
|
US8017237B2
(en)
|
2006-06-23 |
2011-09-13 |
Abbott Cardiovascular Systems, Inc. |
Nanoshells on polymers
|
US20090280188A1
(en)
|
2006-06-23 |
2009-11-12 |
Northwestern University |
Asymmetric functionalizated nanoparticles and methods of use
|
JP2010507361A
(ja)
*
|
2006-07-31 |
2010-03-11 |
キュアバック ゲーエムベーハー |
具体的には免疫刺激剤/アジュバントとしての、一般式(I):GlXmGn、または一般式(II):ClXmCnで表される核酸
|
US20080124366A1
(en)
|
2006-08-06 |
2008-05-29 |
Ohlfest John R |
Methods and Compositions for Treating Tumors
|
MX2009001461A
(es)
|
2006-08-08 |
2009-07-02 |
Univ Texas |
Suministro por etapas multiples de agentes activos.
|
SI2068918T1
(sl)
|
2006-09-26 |
2012-09-28 |
Infectious Disease Res Inst |
Si - ep sestavek za cepljenje, ki vsebuje sintetiäśna pomagala
|
US20100099858A1
(en)
|
2006-09-28 |
2010-04-22 |
Mirkin Chad A |
Maximizing Oligonucleotide Loading on Gold Nanoparticle
|
EP1914234A1
(en)
|
2006-10-16 |
2008-04-23 |
GPC Biotech Inc. |
Pyrido[2,3-d]pyrimidines and their use as kinase inhibitors
|
US7976743B2
(en)
|
2006-10-16 |
2011-07-12 |
Northwestern University |
Gas-containing liposomes
|
CA2671883A1
(en)
|
2006-12-12 |
2008-06-19 |
Idera Pharmaceuticals, Inc. |
Synthetic agonists of tlr9
|
US20080181928A1
(en)
|
2006-12-22 |
2008-07-31 |
Miv Therapeutics, Inc. |
Coatings for implantable medical devices for liposome delivery
|
US8415461B2
(en)
|
2007-01-19 |
2013-04-09 |
The Board Of Trustees Of The University Of Illinois |
Amphiphilic substances and functionalized lipid vesicles including the same
|
US20100144848A1
(en)
|
2007-01-24 |
2010-06-10 |
Syddansk Universitet |
Dna controlled assembly of lipid membranes
|
EP2121987B1
(en)
|
2007-02-09 |
2012-06-13 |
Northwestern University |
Particles for detecting intracellular targets
|
CA2679586A1
(en)
|
2007-02-27 |
2008-10-23 |
Northwestern University |
Molecule attachment to nanoparticles
|
MX2009010479A
(es)
|
2007-03-30 |
2009-10-19 |
Otsuka Pharma Co Ltd |
Liposoma transpulmonar para controlar la llegada del farmaco.
|
EP2144600A4
(en)
|
2007-04-04 |
2011-03-16 |
Massachusetts Inst Technology |
POLY (AMINIC ACID) TARGET MOLECULES
|
EP2146794B1
(en)
|
2007-04-12 |
2016-10-19 |
Biomet Biologics, LLC |
Buoy suspension fractionation system
|
WO2008142513A2
(en)
|
2007-05-18 |
2008-11-27 |
Coley Pharmaceutical Gmbh |
Phosphate-modified oligonucleotide analogs with immunostimulatory activity
|
CN101765423B
(zh)
|
2007-05-31 |
2014-08-06 |
安特里奥公司 |
核酸纳米粒子和其用途
|
US8278043B2
(en)
|
2007-06-05 |
2012-10-02 |
Melica Hb |
Methods and materials related to grey alleles
|
CN101795715A
(zh)
|
2007-07-09 |
2010-08-04 |
艾德拉药物股份有限公司 |
稳定化免疫调控性rna(simra)化合物
|
EP2176411B1
(en)
|
2007-07-23 |
2012-04-18 |
Aarhus Universitet |
Nanoparticle-mediated treatment for inflammatory diseases
|
RU2468819C2
(ru)
|
2007-08-01 |
2012-12-10 |
Идера Фармасьютикалз, Инк. |
Новые синтетические агонисты tlr9
|
JP4847609B2
(ja)
*
|
2007-08-13 |
2011-12-28 |
コーリー ファーマシューティカル ゲーエムベーハー |
特異的な免疫修飾プロフィールを誘発する規定されたヌクレオチド間結合との関連におけるrna配列モチーフ
|
JP2010536787A
(ja)
|
2007-08-15 |
2010-12-02 |
イデラ ファーマシューティカルズ インコーポレイテッド |
Toll様受容体モジュレータ
|
US8563527B2
(en)
|
2007-08-20 |
2013-10-22 |
Pharmain Corporation |
Oligonucleotide core carrier compositions for delivery of nucleic acid-containing therapeutic agents, methods of making and using the same
|
US9421254B2
(en)
|
2007-09-24 |
2016-08-23 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Immunostimulatory combinations of TLR ligands and methods of use
|
US8399005B2
(en)
|
2007-10-12 |
2013-03-19 |
University Of North Carolina At Chapel Hill |
Use of nitric oxide to enhance the efficacy of silver and other topical wound care agents
|
WO2009058907A2
(en)
|
2007-10-29 |
2009-05-07 |
Isis Pharmaceuticals, Inc. |
Targeting micrornas for the treatment of liver cancer
|
EP2058397A1
(de)
|
2007-11-07 |
2009-05-13 |
Mologen AG |
Multimeres Assemblat zur Immunstimulation
|
EP2207903A4
(en)
|
2007-11-09 |
2012-02-15 |
Univ Northeastern |
SELF-ASSEMBLING MICELLES NANOPARTICLES FOR SYSTEMIC GENE DELIVERY
|
US20090148384A1
(en)
|
2007-12-10 |
2009-06-11 |
Fischer Katrin |
Functionalized, solid polymer nanoparticles comprising epothilones
|
WO2009073984A1
(en)
|
2007-12-12 |
2009-06-18 |
University Health Network |
High-density lipoprotein-like peptide-phospholipid scaffold ('hpps') nanoparticles
|
US8741337B2
(en)
|
2008-01-04 |
2014-06-03 |
Aveka, Inc. |
Encapsulation of oxidatively unstable compounds
|
US8481508B2
(en)
|
2008-02-21 |
2013-07-09 |
University Of Kentucky Research Foundation |
Ultra-small RNAs as toll-like receptor-3 antagonists
|
BRPI0910036B8
(pt)
|
2008-03-25 |
2021-05-25 |
Juvaris Biotherapeutics Inc |
kit compreendendo um primeiro administrador para via intra-venosa de um complexo de lipídio catiônico-dna (cldc) e um segundo administrador de uma vacina
|
EP2105145A1
(en)
|
2008-03-27 |
2009-09-30 |
ETH Zürich |
Method for muscle-specific delivery lipid-conjugated oligonucleotides
|
JP2011518222A
(ja)
|
2008-04-21 |
2011-06-23 |
スリーエム イノベイティブ プロパティズ カンパニー |
酸化窒素放出組成物、デバイス、及び方法
|
DK2288336T3
(en)
|
2008-04-25 |
2017-03-13 |
Univ Northwestern |
NANOSTRUCTURES SUITABLE FOR COMPLEXATION OF CHOLESTEROL
|
CN102170903B
(zh)
*
|
2008-05-02 |
2016-04-06 |
亮点医疗有限公司 |
用于刺激免疫反应的产品和方法
|
US8063131B2
(en)
|
2008-06-18 |
2011-11-22 |
University Of Washington |
Nanoparticle-amphipol complexes for nucleic acid intracellular delivery and imaging
|
US8268796B2
(en)
|
2008-06-27 |
2012-09-18 |
Children's Hospital & Research Center At Oakland |
Lipophilic nucleic acid delivery vehicle and methods of use thereof
|
KR20110044764A
(ko)
|
2008-07-28 |
2011-04-29 |
이데라 파마슈티칼즈, 인코포레이티드 |
안티센스 올리고누클레오티드에 의한 톨-유사 수용체 9 발현의 조절
|
WO2010017154A2
(en)
|
2008-08-04 |
2010-02-11 |
Idera Pharmaceuticals, Inc. |
Modulation of toll-like receptor 3 expression by antisense oligonucleotides
|
US20100047188A1
(en)
|
2008-08-04 |
2010-02-25 |
Idera Pharmaceuticals, Inc. |
Modulation of toll-like receptor 8 expression by antisense oligonucleotides
|
CN102171235A
(zh)
|
2008-08-08 |
2011-08-31 |
艾德拉药物股份有限公司 |
通过反义寡核苷酸来调制髓样分化初级应答基因88(MyD88)表达
|
EP2328613A1
(en)
|
2008-08-28 |
2011-06-08 |
GlaxoSmithKline Biologicals S.A. |
Vaccine
|
WO2010037402A1
(en)
|
2008-10-02 |
2010-04-08 |
Dako Denmark A/S |
Molecular vaccines for infectious disease
|
WO2010042877A1
(en)
|
2008-10-09 |
2010-04-15 |
Tekmira Pharmaceuticals Corporation |
Improved amino lipids and methods for the delivery of nucleic acids
|
CA2737352C
(en)
|
2008-10-16 |
2017-06-27 |
University Of Saskatchewan |
Combination adjuvant formulation
|
US8574582B2
(en)
|
2008-10-31 |
2013-11-05 |
Janssen Biotech, Inc. |
Methods for mediating fibrotic response
|
US20130090457A1
(en)
|
2008-10-31 |
2013-04-11 |
Janssen Biotech, Inc. |
Toll-Like Receptor 3 Antagonists for the Treatment of Metabolic and Cardiovascular Diseases
|
CN102215820A
(zh)
|
2008-11-17 |
2011-10-12 |
安龙制药公司 |
用于核酸输送系统的可释放融合脂质
|
DK2370112T3
(en)
*
|
2008-11-24 |
2017-07-24 |
Bonus Cellora Ltd |
IMPLANTABLE LIPOSOM INHIBITED MATRIX COMPOSITION AND APPLICATIONS THEREOF
|
DK2365803T3
(en)
|
2008-11-24 |
2018-01-22 |
Univ Northwestern |
POLYVALENT RNA NANOPARTICLE COMPOSITIONS
|
EP2376107B1
(en)
|
2008-12-09 |
2014-05-21 |
Coley Pharmaceutical Group, Inc. |
Immunostimulatory oligonucleotides
|
WO2010078516A2
(en)
|
2009-01-01 |
2010-07-08 |
Cornell University |
Multifunctional nucleic acid nano-structures
|
US20100184844A1
(en)
|
2009-01-08 |
2010-07-22 |
Northwestern University |
Inhibition of Bacterial Protein Production by Polyvalent Oligonucleotide Modified Nanoparticle Conjugates
|
US20100233270A1
(en)
|
2009-01-08 |
2010-09-16 |
Northwestern University |
Delivery of Oligonucleotide-Functionalized Nanoparticles
|
WO2010085959A1
(en)
|
2009-01-28 |
2010-08-05 |
Aarhus Universitet |
Treatment of radiation-induced fibrosis
|
CN102300990A
(zh)
|
2009-01-30 |
2011-12-28 |
艾德拉药物股份有限公司 |
Tlr9的合成激动剂
|
WO2010091293A1
(en)
|
2009-02-06 |
2010-08-12 |
The Regents Of The University Of California |
Plasmonic system for detecting binding of biological molecules
|
AR070368A2
(es)
|
2009-02-12 |
2010-03-31 |
Smithkline Beecham Biolog |
Procedimiento para la preparacion de una composicion de vacuna que comprende un inmunoestimulante un antigeno y una sal metalica y uso de dicha composicion para preparar un medicamento.composicion de vacuna
|
JP6032724B2
(ja)
|
2009-03-12 |
2016-11-30 |
アルナイラム ファーマシューティカルズ, インコーポレイテッドAlnylam Pharmaceuticals, Inc. |
脂質製剤組成物およびEg5遺伝子とVEGF遺伝子の発現を阻害する方法
|
CN102625842A
(zh)
|
2009-03-13 |
2012-08-01 |
艾根股份有限公司 |
用于输送生物活性rna的组合物和方法
|
JP6145270B2
(ja)
|
2009-04-15 |
2017-06-07 |
ノースウェスタン ユニバーシティ |
オリゴヌクレオチド機能化ナノ粒子の送達
|
EP2246433A1
(de)
|
2009-04-30 |
2010-11-03 |
Mologen AG |
Concatemere zur Immunmodulation
|
KR101360432B1
(ko)
|
2009-06-18 |
2014-02-25 |
한림대학교 산학협력단 |
리포좀에 포집된 올리고뉴클레오타이드를 유효성분으로 하는 면역증강 조성물
|
KR101435953B1
(ko)
|
2009-07-17 |
2014-09-02 |
한림대학교 산학협력단 |
리포좀에 포집된 올리고뉴클레오타이드 및 에피토프를 포함하는 면역증강용 조성물
|
WO2011017382A2
(en)
*
|
2009-08-03 |
2011-02-10 |
The Regents Of The University Of California |
Nanofibers and morphology shifting micelles
|
US20120277283A1
(en)
|
2009-08-04 |
2012-11-01 |
Mirkin Chad A |
Localized Delivery of Gold Nanoparticles for Therapeutic and Diagnostic Applications
|
WO2011017690A2
(en)
|
2009-08-07 |
2011-02-10 |
Northwestern University |
Intracellular delivery of contrast agents with functionalized nanoparticles
|
ES2538347T3
(es)
|
2009-08-27 |
2015-06-19 |
Idera Pharmaceuticals, Inc. |
Composiciones para inhibir expresión genética y usos de las mismas
|
WO2011028847A1
(en)
|
2009-09-01 |
2011-03-10 |
Northwestern University |
Polyvalent polynucleotide nanoparticle conjugates as delivery vehicles for a chemotherapeutic agent
|
CN102625697A
(zh)
|
2009-09-01 |
2012-08-01 |
西北大学 |
使用经寡核苷酸修饰的纳米颗粒作为载体来递送治疗剂
|
US20110053829A1
(en)
|
2009-09-03 |
2011-03-03 |
Curevac Gmbh |
Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids
|
US10525152B2
(en)
|
2009-10-09 |
2020-01-07 |
Signablok, Inc. |
Methods and compositions for targeted imaging
|
KR101132626B1
(ko)
|
2009-10-12 |
2012-04-02 |
주식회사 녹십자 |
난용성 약물의 전달을 위한 고밀도지단백 나노입자의 제조방법
|
US20110111974A1
(en)
|
2009-10-23 |
2011-05-12 |
Northwestern University |
Short Duplex Probes for Enhanced Target Hybridization
|
AU2010313154B2
(en)
|
2009-10-30 |
2016-05-12 |
Northwestern University |
Templated nanoconjugates
|
PT2506857T
(pt)
|
2009-12-01 |
2018-05-14 |
Translate Bio Inc |
Entrega de arnm para o acréscimo de proteínas e enzimas em doenças genéticas humanas
|
WO2011072133A1
(en)
|
2009-12-09 |
2011-06-16 |
William Marsh Rice University |
Therapeutic compositions and methods for delivery of active agents cleavably linked to nanoparticles
|
CA2784547A1
(en)
|
2009-12-23 |
2011-06-30 |
Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V. |
Influenza targets
|
WO2011079290A1
(en)
|
2009-12-24 |
2011-06-30 |
Northwestern University |
Oligonucleotide specific uptake of nanoconjugates
|
EP2525780B1
(en)
|
2010-01-19 |
2022-09-07 |
Northwestern University |
Synthetic nanostructures including nucleic acids and/or other entities
|
EP2399608B1
(en)
|
2010-03-05 |
2020-07-08 |
Sebastian Fuchs |
Immunomodulating nanoparticulate composition for use in inhalation therapy
|
US20130101512A1
(en)
|
2010-03-12 |
2013-04-25 |
Chad A. Mirkin |
Crosslinked polynucleotide structure
|
CN102917690B
(zh)
|
2010-03-19 |
2016-08-24 |
麻省理工学院 |
脂质囊泡组合物和使用方法
|
CA2795289A1
(en)
|
2010-04-08 |
2011-10-13 |
Sanford-Burnham Medical Research Institute |
Methods and compositions for enhanced delivery of compounds
|
CA2798074A1
(en)
|
2010-04-27 |
2011-11-03 |
The Johns Hopkins University |
Immunogenic compositions and methods for treating neoplasia
|
ES2816898T3
(es)
|
2010-05-13 |
2021-04-06 |
Sarepta Therapeutics Inc |
Compuestos que modulan la actividad de señalización de las interleucinas 17 y 23
|
KR101198715B1
(ko)
|
2010-05-14 |
2012-11-13 |
한국생명공학연구원 |
핵산 및 친수성 음이온 화합물의 고효율 포획을 위한 비대칭 리포솜 및 이의 제조방법
|
NO2575876T3
(tr)
|
2010-05-26 |
2018-05-05 |
|
|
MX347471B
(es)
|
2010-05-28 |
2017-04-24 |
Zoetis Belgium S A |
Vacunas que comprenden colesterol y cpg como moleculas portadoras-adyuvantes unicas.
|
WO2011156895A2
(en)
|
2010-06-14 |
2011-12-22 |
National Research Council Of Canada |
Magnetic nanoparticles and uses thereof
|
CN103153346A
(zh)
|
2010-06-16 |
2013-06-12 |
戴纳瓦克斯技术公司 |
使用tlr7和/或tlr9抑制剂的治疗方法
|
WO2012006634A2
(en)
|
2010-07-09 |
2012-01-12 |
The Board Of Trustees Of The University Of Illiniois |
Prostate specific antigen (psa) peptide therapy
|
CN103003427B
(zh)
|
2010-07-28 |
2015-08-12 |
国立大学法人北海道大学 |
具有佐剂活性的新型核酸及其应用
|
BR112013002298A2
(pt)
|
2010-07-30 |
2016-05-24 |
Curevac Gmbh |
complexação de ácidos nucleicos com componentes catiônicos reticulados com dissulfeto para transfecção e estimulação imunológica.
|
GB201014026D0
(en)
|
2010-08-20 |
2010-10-06 |
Ucl Business Plc |
Treatment
|
WO2012031205A2
(en)
|
2010-09-03 |
2012-03-08 |
The Brigham And Women's Hospital, Inc. |
Lipid-polymer hybrid particles
|
CA2811601A1
(en)
|
2010-09-24 |
2012-03-29 |
Mallinckrodt Llc |
Aptamer conjugates for targeting of therapeutic and/or diagnostic nanocarriers
|
US20130095039A1
(en)
|
2010-09-30 |
2013-04-18 |
The Board Of Trustees Of The University Of Illinois |
Nucleic acid-mediated shape control of nanoparticles
|
AU2011322553B2
(en)
|
2010-10-26 |
2015-07-02 |
Ac Immune S.A. |
Liposome-based construct comprising a peptide modified through hydrophobic moieties
|
CA2817891C
(en)
|
2010-11-19 |
2021-10-12 |
Idera Pharmaceuticals, Inc. |
Immune regulatory oligonucleotide (iro) compounds to modulate toll-like receptor based immune response
|
WO2012084991A1
(en)
|
2010-12-21 |
2012-06-28 |
Index Pharmaceuticals Ab |
Biologically active oligonucleotides capable of modulating the immune system ii
|
GB201021867D0
(en)
|
2010-12-23 |
2011-02-02 |
Mologen Ag |
Non-coding immunomodulatory DNA construct
|
GB201021873D0
(en)
|
2010-12-23 |
2011-02-02 |
Mologen Ag |
DNA expression construct
|
WO2012099755A1
(en)
|
2011-01-11 |
2012-07-26 |
Alnylam Pharmaceuticals, Inc. |
Pegylated lipids and their use for drug delivery
|
AU2012205490B2
(en)
|
2011-01-12 |
2017-02-02 |
Array Biopharma, Inc. |
Substituted benzoazepines as toll-like receptor modulators
|
AU2012250050B2
(en)
|
2011-04-28 |
2017-04-06 |
Platform Brightworks Two, Ltd. |
Improved parenteral formulations of lipophilic pharmaceutical agents and methods for preparing and using the same
|
US9675561B2
(en)
|
2011-04-28 |
2017-06-13 |
President And Fellows Of Harvard College |
Injectable cryogel vaccine devices and methods of use thereof
|
US9693957B2
(en)
*
|
2011-07-08 |
2017-07-04 |
The University Of North Carolina At Chapel Hill |
Metal bisphosphonate nanoparticles for anti-cancer therapy and imaging and for treating bone disorders
|
US9517277B2
(en)
|
2011-07-15 |
2016-12-13 |
University Of Georgia Research Foundation, Inc. |
Immune-stimulating photoactive hybrid nanoparticles
|
EP2548571A1
(en)
|
2011-07-22 |
2013-01-23 |
Institut Curie |
Compositions having means for targeting at least one antigen to dendritic cells
|
CA2843274A1
(en)
|
2011-07-29 |
2013-02-07 |
Selecta Biosciences, Inc. |
Synthetic nanocarriers that generate humoral and cytotoxic t lymphocyte (ctl) immune responses
|
WO2013033513A1
(en)
|
2011-08-31 |
2013-03-07 |
University Of Georgia Research Foundation, Inc. |
Apoptosis-targeting nanoparticles
|
US20150086985A1
(en)
|
2011-09-11 |
2015-03-26 |
Aurasense, Llc |
Cellular uptake control systems
|
JP6129844B2
(ja)
|
2011-09-14 |
2017-05-17 |
ラナ セラピューティクス インコーポレイテッド |
多量体オリゴヌクレオチド化合物
|
CA2847698C
(en)
|
2011-09-14 |
2020-09-01 |
Northwestern University |
Nanoconjugates able to cross the blood-brain barrier
|
CA2849259A1
(en)
|
2011-09-19 |
2013-03-28 |
The Johns Hopkins University |
Cancer immunotherapy
|
WO2013043569A1
(en)
|
2011-09-20 |
2013-03-28 |
Vical Incorporated |
Synergistic anti-tumor efficacy using alloantigen combination immunotherapy
|
ES2855474T3
(es)
|
2011-10-06 |
2021-09-23 |
Immunovaccine Technologies Inc |
Composiciones de liposomas que comprenden un adyuvante que activa o incrementa la actividad de TLR2 y usos del mismo
|
EP2797632A1
(en)
|
2012-01-01 |
2014-11-05 |
QBI Enterprises Ltd. |
Endo180-targeted particles for selective delivery of therapeutic and diagnostic agents
|
WO2013113326A1
(en)
|
2012-01-31 |
2013-08-08 |
Curevac Gmbh |
Pharmaceutical composition comprising a polymeric carrier cargo complex and at least one protein or peptide antigen
|
JP6375289B2
(ja)
|
2012-04-05 |
2018-08-15 |
マサチューセッツ インスティテュート オブ テクノロジー |
免疫刺激組成物およびその使用方法
|
SG10201603896RA
(en)
|
2012-05-04 |
2016-07-28 |
Pfizer |
Prostate-associated antigens and vaccine-based immunotherapy regimens
|
WO2013173307A1
(en)
|
2012-05-16 |
2013-11-21 |
Neil Desai |
Multi-target modulation for treating fibrosis and inflammatory conditions
|
AU2013266232B2
(en)
|
2012-05-23 |
2017-08-03 |
The Ohio State University |
Lipid nanoparticle compositions for antisense oligonucleotides delivery
|
EP2873674B1
(en)
|
2012-07-13 |
2020-05-06 |
Shin Nippon Biomedical Laboratories, Ltd. |
Chiral nucleic acid adjuvant
|
CN103566377A
(zh)
|
2012-07-18 |
2014-02-12 |
上海博笛生物科技有限公司 |
癌症的靶向免疫治疗
|
WO2014025795A1
(en)
|
2012-08-07 |
2014-02-13 |
Northeastern University |
Compositions for the delivery of rna and drugs into cells
|
US9095625B2
(en)
|
2012-08-31 |
2015-08-04 |
University Of Massachusetts |
Graft-copolymer stabilized metal nanoparticles
|
US9868955B2
(en)
|
2012-09-29 |
2018-01-16 |
Dynavax Technologies Corporation |
Human toll-like receptor inhibitors and methods of use thereof
|
US11001840B2
(en)
|
2013-02-05 |
2021-05-11 |
1Globe Health Institute Llc |
Biodegradable and clinically-compatible nanoparticles as drug delivery carriers
|
US9968673B2
(en)
|
2013-02-26 |
2018-05-15 |
Commissariat á l'ènergie atomique et aux ènergies alternatives |
Immunogenic composition in emulsion form comprising two dispersed phases, one comprising an antigen and the other comprising an immunostimulating agent
|
CN103212089B
(zh)
|
2013-04-07 |
2016-08-24 |
中国科学院上海应用物理研究所 |
一种碳纳米材料-免疫刺激序列复合物的制备方法及其应用
|
US9617544B2
(en)
|
2013-04-11 |
2017-04-11 |
The Board Of Trustees Of The University Of Illinois |
Nanoparticle mediated delivery of siRNA
|
AR095882A1
(es)
|
2013-04-22 |
2015-11-18 |
Hoffmann La Roche |
Terapia de combinación de anticuerpos contra csf-1r humano con un agonista de tlr9
|
GB2514591A
(en)
|
2013-05-30 |
2014-12-03 |
Mologen Ag |
Predictive biomarker for cancer therapy
|
WO2014201245A1
(en)
|
2013-06-12 |
2014-12-18 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Tlr-9 agonist with tlr-7 and/or tlr-8 agonist for treating tumors
|
JP6697384B2
(ja)
|
2013-07-25 |
2020-05-20 |
イグジキュア, インコーポレーテッドExicure, Inc. |
予防的および治療的使用のための免疫刺激剤としての球状の核酸ベース構築物
|
US20160194642A1
(en)
|
2013-07-25 |
2016-07-07 |
Exicure, Inc |
Spherical nucleic acid-based constructs as immunoregulatory agents
|
US20150037374A1
(en)
|
2013-07-31 |
2015-02-05 |
Csl Limited |
Anti-tumor compositions and uses thereof
|
US10568898B2
(en)
|
2013-08-13 |
2020-02-25 |
Northwestern University |
Lipophilic nanoparticles for drug delivery
|
WO2015023941A1
(en)
|
2013-08-16 |
2015-02-19 |
Rana Therapeutics, Inc. |
Oligonucleotides targeting euchromatin regions of genes
|
US9957506B2
(en)
|
2013-09-25 |
2018-05-01 |
Cornell University |
Compounds for inducing anti-tumor immunity and methods thereof
|
KR101465365B1
(ko)
|
2013-10-15 |
2014-11-25 |
성균관대학교산학협력단 |
리포좀 내 고분자 충진된 다중 기능 복합 입자체 및 이의 제조방법
|
WO2015077657A2
(en)
|
2013-11-22 |
2015-05-28 |
City Of Hope |
Stat3 inhibitors and uses thereof
|
CA2932122C
(en)
|
2013-12-03 |
2022-04-19 |
Northwestern University |
Liposomal particles, methods of making same and uses thereof
|
WO2015095811A2
(en)
|
2013-12-20 |
2015-06-25 |
The Board Institute Inc. |
Combination therapy with neoantigen vaccine
|
WO2015108047A1
(ja)
|
2014-01-15 |
2015-07-23 |
株式会社新日本科学 |
免疫誘導活性を有するキラル核酸アジュバンド及び免疫誘導活性剤
|
JPWO2015108048A1
(ja)
|
2014-01-15 |
2017-03-23 |
株式会社新日本科学 |
抗腫瘍作用を有するキラル核酸アジュバンド及び抗腫瘍剤
|
JPWO2015108046A1
(ja)
|
2014-01-15 |
2017-03-23 |
株式会社新日本科学 |
抗アレルギー作用を有するキラル核酸アジュバンド及び抗アレルギー剤
|
US10619210B2
(en)
|
2014-02-07 |
2020-04-14 |
The Johns Hopkins University |
Predicting response to epigenetic drug therapy
|
GB2523187A
(en)
|
2014-02-18 |
2015-08-19 |
Mologen Ag |
Covalently closed non-coding immunomodulatory DNA construct
|
AU2015222102B2
(en)
|
2014-02-28 |
2021-08-19 |
Bayer Animal Health Gmbh |
Immunostimulatory plasmids
|
CN106456532B
(zh)
|
2014-03-05 |
2020-07-24 |
奥比思健康解决方案有限责任公司 |
使用酵母细胞壁颗粒的疫苗递送系统
|
EP3129391A4
(en)
|
2014-04-03 |
2017-12-20 |
Exicure, Inc. |
Self assembling nucleic acid nanostructures
|
US10208309B2
(en)
|
2014-04-04 |
2019-02-19 |
Bioneer Corporation |
Double-stranded oligo RNA targeted to amphiregulin and pharmaceutical composition comprising same for preventing or treating fibrosis or respiratory diseases
|
EP3137105A4
(en)
|
2014-04-30 |
2017-12-27 |
President and Fellows of Harvard College |
Combination vaccine devices and methods of killing cancer cells
|
US10413565B2
(en)
|
2014-04-30 |
2019-09-17 |
Northwestern University |
Nanostructures for modulating intercellular communication and uses thereof
|
WO2015167616A1
(en)
|
2014-05-02 |
2015-11-05 |
Nitor Therapeutics |
Guanosine as an immunepotentiator mediated through toll receptors
|
AU2015269412B2
(en)
*
|
2014-06-04 |
2020-03-12 |
Exicure Operating Company |
Multivalent delivery of immune modulators by liposomal spherical nucleic acids for prophylactic or therapeutic applications
|
TW201620526A
(zh)
|
2014-06-17 |
2016-06-16 |
愛羅海德研究公司 |
用於抑制α-1抗胰蛋白酶基因表現之組合物及方法
|
WO2016010788A1
(en)
|
2014-07-15 |
2016-01-21 |
The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services |
Polyketal particles including a cpg oligodeoxynucleotide for the treatment of lung cancer
|
JP6607925B2
(ja)
|
2014-08-20 |
2019-11-20 |
ノースウェスタン ユニバーシティ |
アンチセンス遺伝子調節のための生体適合性無限配位ポリマーナノ粒子−核酸抱合体
|
AU2015328242A1
(en)
|
2014-10-06 |
2017-04-27 |
Exicure, Inc. |
Anti-TNF compounds
|
CA2973702A1
(en)
|
2015-01-14 |
2016-07-21 |
Exicure, Inc. |
Nucleic acid nanostructures with core motifs
|
WO2016134104A1
(en)
|
2015-02-18 |
2016-08-25 |
Exicure, Inc. |
Immuno-regulatory lipid containing spherical nucleic acids
|
US10078092B2
(en)
|
2015-03-18 |
2018-09-18 |
Northwestern University |
Assays for measuring binding kinetics and binding capacity of acceptors for lipophilic or amphiphilic molecules
|
JP6995627B2
(ja)
|
2015-05-19 |
2022-02-04 |
イエール ユニバーシティ |
病的石灰化状態を治療するための組成物およびそれを使用する方法
|
AU2016294594A1
(en)
|
2015-07-14 |
2018-02-08 |
Exicure, Inc. |
Spherical nucleic acid (SNA)-mediated delivery of lipid-complexes to cells
|
AU2016312530A1
(en)
|
2015-08-24 |
2018-03-01 |
Halo-Bio Rnai Therapeutics, Inc. |
Polynucleotide nanoparticles for the modulation of gene expression and uses thereof
|
US20200297867A1
(en)
|
2016-02-01 |
2020-09-24 |
Exicure, Inc. |
Surface functionalization of liposomes and liposomal spherical nucleic acids (snas)
|
US20170240960A1
(en)
*
|
2016-02-24 |
2017-08-24 |
Aurasense, Llc |
Spherical nucleic acids (sna) flare based fluorescence in situ hybridization
|
US20190142739A1
(en)
|
2016-04-19 |
2019-05-16 |
Exicure, Inc. |
Topical administration of therapeutic agents and oligonucleotide formulations
|
KR20190003985A
(ko)
|
2016-05-06 |
2019-01-10 |
엑시큐어, 인크. |
구형 핵산 tlr9 효능제
|
AU2017261357A1
(en)
|
2016-05-06 |
2018-11-29 |
Exicure Operating Company |
TLR9-targeted Spherical Nucleic Acids having potent antitumor activity
|
CN109415731A
(zh)
|
2016-05-06 |
2019-03-01 |
埃克西奎雷股份有限公司 |
呈递用于特异性敲低白介素17受体mRNA的反义寡核苷酸(ASO)的脂质体球形核酸(SNA)构建体
|
WO2018053508A1
(en)
|
2016-09-19 |
2018-03-22 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for inducing an immune response
|
US20200248183A1
(en)
|
2017-04-03 |
2020-08-06 |
Subbarao Nallagatla |
Tlr9-targeted spherical nucleic acids having potent antitumor activity
|
US11696954B2
(en)
|
2017-04-28 |
2023-07-11 |
Exicure Operating Company |
Synthesis of spherical nucleic acids using lipophilic moieties
|
US20210002640A1
(en)
|
2018-02-28 |
2021-01-07 |
Exicure, Inc. |
Liposomal spherical nucleic acid (sna) constructs for survival of motor neuron (sma) inhibitors
|
WO2019168558A1
(en)
|
2018-02-28 |
2019-09-06 |
Exicure, Inc. |
Liposomal spherical nucleic acid (sna) constructs for survival of motor neuron (sma) inhibitors
|
EP3923957A4
(en)
|
2019-02-12 |
2022-11-02 |
Exicure Operating Company |
COMBINED SPHERICAL NUCLEIC ACID AND CHECKPOINT INHIBITOR FOR ANTITUMORS THERAPY
|
WO2020219985A1
(en)
|
2019-04-26 |
2020-10-29 |
Exicure, Inc. |
Administration of spherical nucleic acids for ophthalmological uses
|